Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Carbone

Showing results (61-70 of 651) with videos related to

Pageof 66
Sort By:
Respirology (Carlton, Vic.)|January 9, 2007
Proteomics analysis in lung cancer: challenges and opportunitiesTakefumi Kikuchi, David P Carbone
Seminars in Oncology|December 1, 1986
The clinical investigator and the evolution of the treatment of primary breast cancerP P Carbone, D C Tormey
Journal of the National Cancer Institute|October 5, 1994
In vivo gene therapy of human lung cancer using wild-type p53 delivered by retrovirusD P Carbone, J D Minna
Respiratory Research|December 4, 2003
The molecular basis of lung cancer: molecular abnormalities and therapeutic implicationsPierre P Massion, David P Carbone
The Medical Clinics of North America|March 1, 1992
The health consequences of smoking. CancerP A Newcomb, P P Carbone
Hospital Practice (Office Ed.)|December 15, 1991
Adenocarcinoma of the liver without a detectable primaryJ L Abbruzzese, P P Carbone
Molecular Medicine Today|April 1, 1997
p53 as a target for anti-cancer immunotherapyH L Chen, D P Carbone
Acta Haematologica|January 1, 1982
Marker chromosome 14q+ in a case of Ph1-positive chronic myeloid leukemia in lymphoid blastic crisis at presentationP Carbone, G Barbata, F Caronia
Human Genetics|January 1, 1983
Inherited pericentric inversion of human chromosome 5G Barbata, G Granata, P Carbone
Current Opinion in Oncology|June 10, 1998
Immunotherapy of head and neck cancerJ R Resser, D P Carbone
Pageof 66

Showing results (61-70 of 651) with videos related to

Sort By:
Pageof 66
Respirology (Carlton, Vic.)|January 9, 2007
Proteomics analysis in lung cancer: challenges and opportunitiesTakefumi Kikuchi, David P Carbone
Seminars in Oncology|December 1, 1986
The clinical investigator and the evolution of the treatment of primary breast cancerP P Carbone, D C Tormey
Journal of the National Cancer Institute|October 5, 1994
In vivo gene therapy of human lung cancer using wild-type p53 delivered by retrovirusD P Carbone, J D Minna
Respiratory Research|December 4, 2003
The molecular basis of lung cancer: molecular abnormalities and therapeutic implicationsPierre P Massion, David P Carbone
The Medical Clinics of North America|March 1, 1992
The health consequences of smoking. CancerP A Newcomb, P P Carbone
Hospital Practice (Office Ed.)|December 15, 1991
Adenocarcinoma of the liver without a detectable primaryJ L Abbruzzese, P P Carbone
Molecular Medicine Today|April 1, 1997
p53 as a target for anti-cancer immunotherapyH L Chen, D P Carbone
Acta Haematologica|January 1, 1982
Marker chromosome 14q+ in a case of Ph1-positive chronic myeloid leukemia in lymphoid blastic crisis at presentationP Carbone, G Barbata, F Caronia
Human Genetics|January 1, 1983
Inherited pericentric inversion of human chromosome 5G Barbata, G Granata, P Carbone
Current Opinion in Oncology|June 10, 1998
Immunotherapy of head and neck cancerJ R Resser, D P Carbone
Pageof 66